Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV.

Lee SK, Dykxhoorn DM, Kumar P, Ranjbar S, Song E, Maliszewski LE, François-Bongarçon V, Goldfeld A, Swamy NM, Lieberman J, Shankar P.

Blood. 2005 Aug 1;106(3):818-26. Epub 2005 Apr 14.

PMID:
15831707
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.

Chang LJ, Liu X, He J.

Gene Ther. 2005 Jul;12(14):1133-44. Erratum in: Gene Ther. 2005 Aug;12(16):1289.

PMID:
15750613
[PubMed - indexed for MEDLINE]
3.

Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol.

Morris KV, Chung CH, Witke W, Looney DJ.

RNA Biol. 2005 Jan;2(1):17-20. Epub 2005 Jan 27.

PMID:
17132935
[PubMed - indexed for MEDLINE]
Free Article
4.

Silencing of HIV-1 with RNA interference: a multiple shRNA approach.

ter Brake O, Konstantinova P, Ceylan M, Berkhout B.

Mol Ther. 2006 Dec;14(6):883-92. Epub 2006 Sep 7.

PMID:
16959541
[PubMed - indexed for MEDLINE]
5.

Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.

ter Brake O, Berkhout B.

J Gene Med. 2007 Sep;9(9):743-50.

PMID:
17628029
[PubMed - indexed for MEDLINE]
6.

Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag.

Cave E, Weinberg MS, Cilliers T, Carmona S, Morris L, Arbuthnot P.

AIDS Res Hum Retroviruses. 2006 May;22(5):401-10.

PMID:
16706616
[PubMed - indexed for MEDLINE]
7.

The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5' long terminal repeat.

Barichievy S, Saayman S, von Eije KJ, Morris KV, Arbuthnot P, Weinberg MS.

Oligonucleotides. 2007 Winter;17(4):419-31.

PMID:
17896874
[PubMed - indexed for MEDLINE]
8.

Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.

von Eije KJ, ter Brake O, Berkhout B.

J Gene Med. 2009 Jun;11(6):459-67. doi: 10.1002/jgm.1329.

PMID:
19384894
[PubMed - indexed for MEDLINE]
9.

Lentiviral delivery of RNAi effectors against HIV-1.

Liu YP, Berkhout B.

Curr Top Med Chem. 2009;9(12):1130-43. Review.

PMID:
19860713
[PubMed - indexed for MEDLINE]
10.

HIV-1-specific RNA interference.

Boden D, Pusch O, Ramratnam B.

Curr Opin Mol Ther. 2004 Aug;6(4):373-80. Review.

PMID:
15468596
[PubMed - indexed for MEDLINE]
11.

Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.

Kraus G, Geffin R, Spruill G, Young AK, Seivright R, Cardona D, Burzawa J, Hnatyszyn HJ.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3406-11.

PMID:
11904403
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.

Butticaz C, Ciuffi A, Muñoz M, Thomas J, Bridge A, Pebernard S, Iggo R, Meylan P, Telenti A.

Antivir Ther. 2003 Oct;8(5):373-7.

PMID:
14640383
[PubMed - indexed for MEDLINE]
13.

HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.

Senserrich J, Pauls E, Armand-Ugón M, Clotet-Codina I, Moncunill G, Clotet B, Esté JA.

Virology. 2008 Mar 15;372(2):421-9. Epub 2007 Dec 18.

PMID:
18068205
[PubMed - indexed for MEDLINE]
Free Article
14.

Lentiviral-mediated delivery of siRNAs for antiviral therapy.

Morris KV, Rossi JJ.

Gene Ther. 2006 Mar;13(6):553-8. Review.

PMID:
16397511
[PubMed - indexed for MEDLINE]
15.

[Screening of highly effective siRNA sequence targeting to HIV-1 vif and the lentiviral-mediated antiviral research in vitro].

Zhang T, Cheng T, Zhang YL, Wei LH, Cai YJ, Zhang J, Zhu H, Han JH, Xia NS.

Bing Du Xue Bao. 2008 Jun;24(2):88-95. Chinese.

PMID:
18533339
[PubMed - indexed for MEDLINE]
16.

RNA interference targeted to the conserved dimerization initiation site (DIS) of HIV-1 restricts virus escape mutation.

Sugiyama R, Habu Y, Ohnari A, Miyano-Kurosaki N, Takaku H.

J Biochem. 2009 Oct;146(4):481-9. doi: 10.1093/jb/mvp093. Epub 2009 Jun 24.

PMID:
19556221
[PubMed - indexed for MEDLINE]
17.

Design of extended short hairpin RNAs for HIV-1 inhibition.

Liu YP, Haasnoot J, Berkhout B.

Nucleic Acids Res. 2007;35(17):5683-93. Epub 2007 Aug 21.

PMID:
17715143
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches.

Gitlin L, Stone JK, Andino R.

J Virol. 2005 Jan;79(2):1027-35.

PMID:
15613331
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.

Verheyen J, Litau E, Sing T, Däumer M, Balduin M, Oette M, Fätkenheuer G, Rockstroh JK, Schuldenzucker U, Hoffmann D, Pfister H, Kaiser R.

Antivir Ther. 2006;11(7):879-87.

PMID:
17302250
[PubMed - indexed for MEDLINE]
20.

Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.

ter Brake O, 't Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B.

Mol Ther. 2008 Mar;16(3):557-64. doi: 10.1038/sj.mt.6300382. Epub 2008 Jan 15.

PMID:
18180777
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk